What is Sarepta Therapeutics, Inc.'s asset turnover?

Sarepta Therapeutics, Inc. (SRPT) reported asset turnover of 0.7× in Q1 2026.

What is the long-term trend for Sarepta Therapeutics, Inc.'s asset turnover?

Over 4 years (2020 to 2025), Sarepta Therapeutics, Inc.'s asset turnover has grown at a 27.9% compound annual growth rate (CAGR), from 0.2× to 0.6×.

What does asset turnover mean?

Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

Sarepta Therapeutics, Inc. SRPT Asset turnover

Asset turnover at other companies

PfizerPFE

0.3×0.0×

Regeneron PharmaceuticalsREGN

0.4×0.0×

BioMarin PharmaceuticalsBMRN

0.4×0.0×

PTC TherapeuticsPTCT

0.3×-0.5×

InsmedINSM

0.4×+0.2×

Capricor TherapeuticsCAPR

0×—

Other financials

Income statement

See full

Revenue$730.8M-1.9%

Operating income-$300.4M-961%

Net income$331.0M+174%

EPS (diluted)-$4.60-1,343%

Balance sheet

See full

Cash & equivalents$464.5M+92.8%

Total debt$198.5M-3.4%

Total equity$1.5B+31.7%

Total assets$3.2B-8.3%

Cash flow

See full

Operating cash flow-$202.7M+65.3%

CapEx$2.1M-95.2%

Free cash flow-$204.8M+67.3%

Valuation

See full

Market cap$1.82B-63.1%

Enterprise value$1.56B-67.2%

P/S0.8×—

Profitability

See full

Operating margin-50.8%-1.6pp

Net margin4.6%+2.4pp

FCF margin-28.7%-9.2pp

Returns & leverage

See full

Return on equity-23.6%-28.5pp

Debt / equity0.1×0.0×

Current ratio4.6×+0.6×

Where this comes from

Calculated from Sarepta Therapeutics, Inc.’s reported figures.

total revenue/total assets=0.7×

Based on trailing twelve months.

The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s asset turnover?: Sarepta Therapeutics, Inc. (SRPT) reported asset turnover of 0.7× in Q1 2026.
What is the long-term trend for Sarepta Therapeutics, Inc.'s asset turnover?: Over 4 years (2020 to 2025), Sarepta Therapeutics, Inc.'s asset turnover has grown at a 27.9% compound annual growth rate (CAGR), from 0.2× to 0.6×.
What does asset turnover mean?: Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.